East Ocean Capital (Hong Kong) Company Limited - Net Worth and Insider Trading

East Ocean Capital (Hong Kong) Company Limited Net Worth

The estimated net worth of East Ocean Capital (Hong Kong) Company Limited is at least $951 Million dollars as of 2024-09-19. East Ocean Capital (Hong Kong) Company Limited is the 2101 Beneficial owner of Grand Pharmaceutical Group Ltd and owns about 224,373,091 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) stock worth over $951 Million. Details can be seen in East Ocean Capital (Hong Kong) Company Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that East Ocean Capital (Hong Kong) Company Limited has not made any transactions after 2022-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of East Ocean Capital (Hong Kong) Company Limited

To

East Ocean Capital (Hong Kong) Company Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, East Ocean Capital (Hong Kong) Company Limited owns 1 companies in total, including Grand Pharmaceutical Group Ltd (HKSE:00512) .

Click here to see the complete history of East Ocean Capital (Hong Kong) Company Limited’s form 4 insider trades.

Insider Ownership Summary of East Ocean Capital (Hong Kong) Company Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:00512 Grand Pharmaceutical Group Ltd 2022-12-23 2101 Beneficial owner

East Ocean Capital (Hong Kong) Company Limited Latest Holdings Summary

East Ocean Capital (Hong Kong) Company Limited currently owns a total of 1 stock. East Ocean Capital (Hong Kong) Company Limited owns 224,373,091 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) as of December 23, 2022, with a value of $951 Million.

Latest Holdings of East Ocean Capital (Hong Kong) Company Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:00512 Grand Pharmaceutical Group Ltd 2022-12-23 224,373,091 4.24 951,341,906

Holding Weightings of East Ocean Capital (Hong Kong) Company Limited


East Ocean Capital (Hong Kong) Company Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, East Ocean Capital (Hong Kong) Company Limited has made a total of 2 transactions in Grand Pharmaceutical Group Ltd (HKSE:00512) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Grand Pharmaceutical Group Ltd is the acquisition of 6,197,388 shares on December 23, 2022, which cost East Ocean Capital (Hong Kong) Company Limited around $0.

Insider Trading History of East Ocean Capital (Hong Kong) Company Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

East Ocean Capital (Hong Kong) Company Limited Trading Performance

GuruFocus tracks the stock performance after each of East Ocean Capital (Hong Kong) Company Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by East Ocean Capital (Hong Kong) Company Limited is 8.14%. GuruFocus also compares East Ocean Capital (Hong Kong) Company Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by East Ocean Capital (Hong Kong) Company Limited within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how East Ocean Capital (Hong Kong) Company Limited's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of East Ocean Capital (Hong Kong) Company Limited

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.49 LIMIT LIMIT LIMIT LIMIT LIMIT

East Ocean Capital (Hong Kong) Company Limited Ownership Network

Ownership Network List of East Ocean Capital (Hong Kong) Company Limited

No Data

Ownership Network Relation of East Ocean Capital (Hong Kong) Company Limited

Insider Network Chart

East Ocean Capital (Hong Kong) Company Limited Owned Company Details

What does Grand Pharmaceutical Group Ltd do?

Who are the key executives at Grand Pharmaceutical Group Ltd?

East Ocean Capital (Hong Kong) Company Limited is the 2101 Beneficial owner of Grand Pharmaceutical Group Ltd. Other key executives at Grand Pharmaceutical Group Ltd include 2101 Beneficial owner Shang Hai Yuan Da Chan Rong Tou Zi Guan Li You Xian Gong Si , 2201 Interest of corporation controlled by you Hu Kaijun , and 2201 Interest of corporation controlled by you Lion River I N.V. .

Grand Pharmaceutical Group Ltd (HKSE:00512) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Grand Pharmaceutical Group Ltd (HKSE:00512)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Grand Pharmaceutical Group Ltd Insider Transactions

No Available Data

East Ocean Capital (Hong Kong) Company Limited Mailing Address

Above is the net worth, insider trading, and ownership report for East Ocean Capital (Hong Kong) Company Limited. Currently GuruFocus does not have mailing address information for East Ocean Capital (Hong Kong) Company Limited.

Discussions on East Ocean Capital (Hong Kong) Company Limited

No discussions yet.